$TXHD .02 cent price target from Ludlow. Last trade .0011.

New Post Public Reply Private Reply Replies (0) Message Board
makebucks
$TXHD .02 cent price target from Ludlow. Last trade .0011.





TXHD SMS Text Marketing Platform Draws Interest from Investors

December 20, 2016 wallstreetnewscast Leave a comment










(NEW YORK)–The growth in SMS mobile text marketing has been grabbing the attention of investors as the old world of email promotion makes way for the new world, which is promotion offers right to your phone.



According to research by The Wireless Association, the open rate of text promotions/offers is a whopping 98%, while the open rate of emails is a just 22%. An email might sit in a customer’s inbox all day, but people’s phones will sit in their pockets or even better in their hand, and are much more likely to see the promotion then with email. This makes text a read within minutes, making it a great channel for flash sales and same-day promotions.

This explosion in SMS mobile text marketing has put a bullish light on stocks within this arena. One of the bigger players, Twilio (NYSE:TWLO) offers contextual SMS marketing by embedding messaging, voice, and video capabilities directly into their software applications. Founded in 2008,Twilio has over 650 employees, and currently trades at a $2.6 billion market cap after their successful IPO in June 2016. www.twilio.com

A smaller player within this sector gaining attention is Textmunication Holdings (OTCMKTS:TXHD), which develops an online mobile marketing platform service that also helps customers communicate with their members by allowing them to build loyalty, engage member retention, and create new business through a non-intrusive, value added medium. Clients on TXHD platform can send their most up-to-date offers, discounts, member alerts, events, PT schedules, or any other personalized campaign.

The potential for this market has been grabbing the attention of investors in recent months. Ludlow Research, an small cap equity research firm based out of New York City, just today added TXHD to their trader “watch list” based on the company’s low market capital valuation, and potential market growth.

In a note to their subscribers, Ludlow commented that with around 180 million shares issued and outstanding, and their growing base of vertical clients and revenue operations, the company may provide a value trade based on a market cap of only around $180,000 at a price of $0.0009 per share. They added with the retirement of prior toxic notes, and growing interest in SMS mobile marketing, they gave TXHD stock a “speculative” target of $0.02 per share, or conservative $4 million market valuation.

About Textmunication

Textmunication is an online mobile marketing platform service provider that helps health clubs and martial arts studios communicate with their members by allowing them to build loyalty, engage member retention, and create new business through a non-intrusive, value added medium. Textmunication connects members to the content they desire through any mobile device for health clubs and studio events, as well as promotions. Clients can send the most up-to-date offers, discounts, member alerts, events, PT schedules, or any other personalized campaign. Text DEMO to shortcode 87365 to sign up for a demonstration on our SMS solution.
www.textmunication.com

To receive news and investors alerts on TXHD just text “TXHD” to 87365
- See more at: http://www.wallstreetnewscast.com/txhd-1220/#...yO3VL.dpuf


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles